Navigation Links
Qforma Appoints Erin McLaughlin as Director, Field Operations
Date:10/29/2009

SANTA FE, N.M., Oct. 29 /PRNewswire/ -- Qforma, an advanced analytics and predictive modeling company, today announced the appointment of Erin McLaughlin to the position of director of field operations.

"Erin is a welcome addition to the Qforma family, and her appointment is the latest highlight in a year marked by company growth and important milestones," said Kelly D. Myers, CEO of Qforma. "Her combined background and expertise in analytics and healthcare will make her a perfect fit for our team and a valued asset to our customers."

As a director of field operations, McLaughlin will be responsible for consulting with the company's scientific team to design a customized project plan and specifications for each customer. She will work with customers throughout the solution implementation process to facilitate and track project progress, provide measurements of results during implementation and assist with final analysis of software deliverables.

McLaughlin comes to Qforma with more than 10 years of experience in the healthcare industry, in both an operational capacity and business development. She began her career with NDCHealth (now Wolters Kluwer Health), where she held positions in sales and management. Most recently, McLaughlin was an account manager with Surveillance Data Inc. (SDI), working with pharmaceutical and biotech company clients on the West Coast.

About Qforma

Qforma is an advanced analytics and predictive modeling company specializing in solutions for the pharmaceutical and biotech industries. Qforma leverages the talents of physicists, mathematicians and programmers, and has developed a unique approach to quantifying large data flows with the purpose of eliminating the inefficiencies of traditional sales and marketing techniques. In May 2009, Qforma launched "Most Influential Doctors" (MID), a first-of-its-kind online database presented by USA TODAY that provides consumers with information about the top community medical leaders in virtually every metropolitan area in the U.S. The recently expanded database is available at www.influentialdoctors.usatoday.com.

Qforma is headquartered in Santa Fe, NM, with offices in Princeton, NJ. More information is located at http://www.Qforma.com.

    Media Contacts:
    Lisa Haley, Qforma
    (505) 603-7596
    lhaley@qforma.com

    Jeff Hoyak, MCS Healthcare Public Relations
    (800) 477-9626, ext. 312
    jeffh@mcspr.com

SOURCE Qforma


'/>"/>
SOURCE Qforma
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. VitaminSpice Appoints Dr. Richard F. Seelig as Director
2. Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs
3. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
4. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
5. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
6. EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales
7. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
8. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
9. CeQur SA Appoints Eric Milledge Chairman of the Board of Directors
10. US HIFU Appoints Arie Belldegrun, M.D. to Board of Directors
11. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology:
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):